Cisplatin/Durvalumab/Gemcitabine Regimen

Preferred Label : Cisplatin/Durvalumab/Gemcitabine Regimen;

NCIt synonyms : Gemcitabine/Cisplatin Plus Durvalumab; Cisplatin/Gemcitabine Plus Durvalumab Regimen; Cisplatin-Durvalumab-Gemcitabine; Cisplatin/Durvalumab/Gemcitabine; Cisplatin-Durvalumab-Gemcitabine Regimen; Cisplatin/Imfinzi/Gemzar;

NCIt related terms : Cisplatin and Gemcitabine (GC) and Durvalumab;

NCIt definition : A regimen consisting of cisplatin, gemacitabine and durvalumab that may be used for the treatment of biliary tract cancer and ampullary adenocarcinoma.;

NCI Metathesaurus CUI : CL1793516;

Codes from synonyms : 15243;

Details

Origin ID

C188464;

UMLS CUI

C5707796;

Est indiqué pour
- Metastatic Biliary Tract Carcinoma [NCIt concept]
- Unresectable Biliary Tract Carcinoma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cisplatin [NCIt concept]
- Durvalumab [NCIt concept]
- Gemcitabine Hydrochloride [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients